| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18.3B | $18.9B | $20.1B | $20.8B | $17.5B | $12.3B | $14.7B | $15.5B |
| Cost of Revenue | $14.9B | $15.2B | $16.6B | $17.0B | $13.7B | $10.3B | $11.6B | $12.0B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.4B | $0.4B | $0.5B | $0.5B | $0.5B | $0.4B | $0.4B | $0.4B |
| SG&A Expense | $2.7B | $2.8B | $2.8B | $2.8B | $2.7B | $2.2B | $2.3B | $2.3B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $-1.7B | $0.1B | $-0.7B | $0.2B | $0.8B | $-1.3B | $-0.3B | $0.7B |
| EPS (Basic) | $-5.99 | $0.24 | $-2.42 | $0.71 | $2.92 | $-5.35 | $-1.33 | $2.92 |
| EPS (Diluted) | $-5.99 | $0.24 | $-2.42 | $0.71 | $2.89 | $-5.35 | $-1.33 | $2.89 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $18.2B | $21.0B | $21.6B | $22.4B | $21.4B | $16.5B | $17.2B | $16.9B |
| Current Assets | $7.2B | $7.6B | $7.7B | $8.7B | $7.3B | $5.6B | $5.9B | $5.9B |
| Cash & Equivalents | $0.8B | $0.8B | $0.9B | $1.2B | $1.1B | $1.5B | $0.9B | $0.8B |
| Total Liabilities | $14.8B | $16.1B | $16.7B | $17.0B | $16.2B | $13.2B | $12.6B | $11.8B |
| Current Liabilities | $6.8B | $7.3B | $7.1B | $7.1B | $6.6B | $5.1B | $5.3B | $4.8B |
| Stockholders' Equity | $3.2B | $4.8B | $4.7B | $5.3B | $5.0B | $3.1B | $4.4B | $4.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.8B | $0.7B | $1.0B | $0.5B | $1.1B | $1.1B | $1.2B | $0.9B |
| Investing Cash Flow | $1.0B | $-1.0B | $-1.0B | $-0.9B | $-2.8B | $-0.7B | $-0.8B | $-0.9B |
| Capital Expenditures | $0.8B | $1.2B | $1.1B | $1.1B | $1.0B | $0.6B | $0.8B | $0.8B |
| Financing Cash Flow | $-1.8B | $0.2B | $-0.3B | $0.6B | $1.3B | $0.2B | $-0.3B | $-0.2B |